                               SEQUENCE LISTING

<110> AGEX THERAPEUTICS, INC.
 
<120> DIFFERENTIALLY-METHYLATED REGIONS OF THE GENOME USEFUL AS MARKERS
      OF EMBRYO-ADULT TRANSITIONS

<130> 125799.0008.00PC00

<140> PCT/US2020/047707
<141> 2020-08-25

<150> 62/891,225
<151> 2019-08-23

<160> 3     

<170> PatentIn version 3.5

<210> 1
<211> 668
<212> DNA
<213> Homo sapiens

<400> 1
cgcaggaagg cggaagggaa ggcggagacc ggcaagagag gggagaaggc ccggggaaga       60

cgctcgggac caagatgcgg ggcccgggtg cgagcagctg aacctctcgg cccccaggcg      120

tggtgacctg ggtggcgacg ctcgtggagg ccgaggagct tctggaccgg cgcttcgggg      180

gaccaagtgg agaggctgct ggagttgtcg cctgagtcct cccttagttc ttcgcgccgg      240

cctcgcccac ggctccgggt cccagccgcc actgcagtct ccgcagcacc gagcggggct      300

ccaccgactc gcgacctcca gcctccgcct caagggcagg gagcgcggct gggtctctgg      360

aaagccattt ttaaatcact gcctctgctg cccccatgtg aggtcggagt gtcctccccc      420

gtctttgctt tcaggttctt tcaggttcct ttgggcaaac ccgcagctaa gagtccagct      480

tgtgaacttg aacctgaact tgctgaagaa gctcccggcg gccccctgct gtctgcggcc      540

tttgtttgag ggagaggctg gggtcacccg gttgggccgc atttccgggg ccgtcacctg      600

tcgggctgcc aggccgcgcg taccttgtcc catcgggggc tctgctctgc cccctgcgct      660

gatgacgc                                                               668


<210> 2
<211> 19
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 2
aggcggagac cggcaagag                                                    19


<210> 3
<211> 22
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 3
agaactaagg gaggactcag gc                                                22


